These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 22825689)

  • 1. What comes after metformin for type 2 diabetes.
    Med Lett Drugs Ther; 2012 Jul; 54(1395):58-9. PubMed ID: 22825689
    [No Abstract]   [Full Text] [Related]  

  • 2. A retrospective cohort study of economic outcomes and adherence to monotherapy with metformin, pioglitazone, or a sulfonylurea among patients with type 2 diabetes mellitus in the United States from 2003 to 2005.
    Hansen RA; Farley JF; Droege M; Maciejewski ML
    Clin Ther; 2010 Jul; 32(7):1308-19. PubMed ID: 20678679
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Insulin sparing and metabolic control with metformin-insulin combination].
    Isnard F
    Journ Annu Diabetol Hotel Dieu; 1997; ():305-25. PubMed ID: 9296986
    [No Abstract]   [Full Text] [Related]  

  • 4. [Thus to avoid complications of diabetes. To combine early].
    MMW Fortschr Med; 2001 Nov; 143(44):60. PubMed ID: 11732409
    [No Abstract]   [Full Text] [Related]  

  • 5. [Capabilities of hypoglycemic therapy in women with decompensated type 2 diabetes mellitus].
    Onuchin SG; Elsukova OS; Solov'ev OV; Onuchina EL
    Ter Arkh; 2010; 82(8):34-41. PubMed ID: 20873243
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glyburide/metformin (Glucovance) for type 2 diabetes.
    Med Lett Drugs Ther; 2000 Nov; 42(1092):105-6. PubMed ID: 11077467
    [No Abstract]   [Full Text] [Related]  

  • 7. Intensifying type 2 diabetes therapy: assessing the options. Introduction.
    Brunton SA
    J Fam Pract; 2011 Sep; 60(9 Suppl):S3. PubMed ID: 21912772
    [No Abstract]   [Full Text] [Related]  

  • 8. Pioglitazone/metformin (Actoplus met).
    Med Lett Drugs Ther; 2006 Jan; 48(1227):9-11. PubMed ID: 16444136
    [No Abstract]   [Full Text] [Related]  

  • 9. Sitagliptin/metformin (Janumet) for type 2 diabetes.
    Med Lett Drugs Ther; 2007 Jun; 49(1262):45-7. PubMed ID: 17541377
    [No Abstract]   [Full Text] [Related]  

  • 10. A comparison of costs for four oral antidiabetic regimens within a managed care population.
    Stockl K; Vanderplas AM; Nicklasson L
    Manag Care Interface; 2003 Jul; 16(7):31-6. PubMed ID: 12908215
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [2-year data of large clinical comparative studies. Type 2 diabetes: lasting metabolic control with pioglitazone].
    MMW Fortschr Med; 2004 Jul; 146(29-30):48-9. PubMed ID: 15540563
    [No Abstract]   [Full Text] [Related]  

  • 12. Insulin regimens in type 2 diabetes.
    Cordido F
    N Engl J Med; 2010 Mar; 362(10):960; author reply 960. PubMed ID: 20225351
    [No Abstract]   [Full Text] [Related]  

  • 13. Metformin: a new treatment option for non-insulin-dependent diabetes mellitus.
    Goo AK; Carson DS; Bjelajac A
    J Fam Pract; 1996 Jun; 42(6):612-8. PubMed ID: 8656173
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Continuation of metformin after introduction of insulin in type 2 diabetes.
    Kooy A
    BMJ; 2009 Nov; 339():b4227. PubMed ID: 19900992
    [No Abstract]   [Full Text] [Related]  

  • 15. Sitagliptin: a novel drug for the treatment of type 2 diabetes.
    Choy M; Lam S
    Cardiol Rev; 2007; 15(5):264-71. PubMed ID: 17700385
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improvement in metformin and insulin utilisation in the Australian veteran population associated with quality use of medicines intervention programs.
    Gadzhanova S; Roughead EE; Loukas K; Vajda J
    Pharmacoepidemiol Drug Saf; 2011 Apr; 20(4):359-65. PubMed ID: 21442685
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metformin.
    Bailey CJ; Turner RC
    N Engl J Med; 1996 Feb; 334(9):574-9. PubMed ID: 8569826
    [No Abstract]   [Full Text] [Related]  

  • 18. [40 years of Metformin in the treatment of diabetes mellitus].
    Internist (Berl); 1997 Jul; 38(7 Suppl 40 Jahre):1-8. PubMed ID: 9330653
    [No Abstract]   [Full Text] [Related]  

  • 19. [Medicines for type 2 diabetes: fine tuning rather than redesign].
    Oberpichler-Schwenk H
    Med Monatsschr Pharm; 2012 May; 35(5):163. PubMed ID: 22624349
    [No Abstract]   [Full Text] [Related]  

  • 20. A short-term cost-of-treatment model for type 2 diabetes: comparison of glipizide gastrointestinal therapeutic system, metformin, and acarbose.
    Ramsdell JW; Grossman JA; Stephens JM; Botteman MF; Arocho R
    Am J Manag Care; 1999 Aug; 5(8):1007-24. PubMed ID: 10558125
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.